Cardio-protective Effect of Metformin in Patients Undergoing PCI
Status:
Active, not recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This is a two-arm randomized parallel study. Patients who will be meeting the above-mentioned
criteria and agree to take part in the study, were asked to sign an informed consent prior
conducting the study.
The whole study protocol were presented to the local institutional review board (IRB).